Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-05, Stock:LLY, The news for the past five days is as follows:
2018-02-26: NEWS1: Lilly breast cancer drug wins expanded U.S. approval.NEWS2: Lilly Receives Additional FDA Approval for VerzenioTM (abemaciclib), as Initial Treatment for Advanced Breast Cancer.NEWS3: Eli Lilly Announces Additional FDA Approval For Verzenio - Quick Facts.NEWS4: Eli Lilly Announces Additional FDA Approval For Verzenio - Quick Facts.NEWS5: Radius Health (RDUS) to Disappoint Investors in Q4 Earnings?.NEWS6: Radius Health (RDUS) to Disappoint Investors in Q4 Earnings?.NEWS7: Health Care Sector Update for 02/26/2018: ACHN, OBSV, EGRX, LLY, CNC.NEWS8: Health Care Sector Update for 02/26/2018: ACHN, OBSV, EGRX, LLY, CNC.NEWS9: Johnson & Johnson’s Neuroscience Segment in 2017.NEWS10: New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes.NEWS11: Eli Lilly Reports New Data From Trulicity Phase 3b Study - Quick Facts.NEWS12: Eli Lilly Reports New Data From Trulicity Phase 3b Study - Quick Facts.
2018-02-27: NEWS1: Eli Lilly Needs to Prove It Can Overcome Resistance Above $82.NEWS2: Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer.NEWS3: Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer.NEWS4: Lilly&apos;s Verzenio Wins FDA Nod for First Line Breast Cancer.NEWS5: Benzinga Pro's 5 Stocks To Watch Today.
2018-02-28: nan
2018-03-01: nan
2018-03-02: NEWS1: Here's Why Radius Health Dropped as Much as 14.7% Today.NEWS2: Here's Why Radius Health Dropped as Much as 14.7% Today.NEWS3: Why Is Eli Lilly (LLY) Down 7.2% Since its Last Earnings Report?.NEWS4: Why Is Eli Lilly (LLY) Down 7.2% Since its Last Earnings Report?.NEWS5: Radius (RDUS) Q4 Loss Wider Than Expected on Higher Expenses.NEWS6: Radius (RDUS) Q4 Loss Wider Than Expected on Higher Expenses.NEWS7: Why Is Eli Lilly (LLY) Down 7.2% Since its Last Earnings Report?.

Answer: Rise